Skip to main content
. Author manuscript; available in PMC: 2010 Oct 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2010 Mar 23;19(4):992–999. doi: 10.1158/1055-9965.EPI-09-1023

Table 2.

Correlation between mRNA expression levels and immunohistochemistry staining levels as measured by pathologists and automated systems

Stain Rho (95% CI) P-value
ER-alpha
 Pathologist 0.67 (0.45-0.89) 4×10−12
 Aperio 0.73 (0.51-0.95) 4×10−15
 TMAx 0.74 (0.52-0.96) 1×10−15
 Ariol 0.67 (0.45-0.89) 2×10−12
PR
 Pathologist 0.77 (0.55-0.99) 6×10−17
 Aperio 0.69 (0.47-0.91) 6×10−13
 TMAx 0.73 (0.51-0.95) 1×10−14
 Ariol 0.73 (0.51-0.95) 5×10−15
HER-2
 Pathologist 0.63 (0.41-0.85) 4×10−10
 Aperio 0.43 (0.21-0.65) 1×10−4
 TMAx 0.49 (0.27-0.71) 4×10−6
 Ariol 0.41 (0.19-0.63) 2×10−4
ER-beta
 Pathologist −0.04 (−0.22-0.22) 0.76
 Aperio 0.09 (−0.13-0.31) 0.43
 TMAx 0.003 (−0.22-0.22) 0.97
 Ariol −0.12 (−0.34-0.1) 0.3
Aromatase
 Pathologist 0.06 (−0.17-0.29) 0.61
 Aperio −0.03 (−0.26-0.2) 0.79
 TMAx 0.04 (−0.19-0.27) 0.76
 Ariol 0.09 (−0.14-0.32) 0.44

For ER-alpha, PR and ER-beta, the combined (intensity x percent) score was used. For HER2 and aromatase, the intensity score was used.

Results are for the expression probe with the highest correlation coefficients.